Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Some people may temporarily lose more hair in certain areas after a hair transplant.

Melanocyte activity in hair follicles is linked to the hair growth cycle, being active in growth phases and inactive in rest phases.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

A reliable system was developed to distinguish hair growth stages, aiding in identifying hair growth promoters or inhibitors.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Telogen effluvium is a common, distressing condition causing excessive hair shedding and has significant psychological effects on patients.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

Estrogen affects hair growth and skin cell multiplication.

Hair count is important to distinguish between genetic hair thinning (Androgenetic Alopecia) and hair thinning caused by disrupted hair growth (Chronic Telogen Effluvium).

Minoxidil and platelet-rich plasma can help turn thin hair into thicker hair in male pattern baldness.

Understanding hair growth involves complex interactions between molecules and could help treat hair disorders.

Telogen effluvium causes sudden hair loss, often due to stress or changes, and is treated by addressing the cause and offering support.

The girl likely has Loose anagen hair syndrome, which may improve on its own or with minoxidil.

Estrogen can temporarily slow down hair growth but this can be reversed.